// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

The impact of a well breast cancer patient transition model of care on oncologists’ practice.

Seungree Nam - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

The impact of age in the quality of life of patients diagnosed with breast cancer after curative treatment.

Adriana Reis Brandao Matutino - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Facilitating patient communication through understanding their social media use: A comparison by age groups.

Shayan Kassirian - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Body mass index (BMI), health behaviors, and perceptions in cancer survivors.

Lawson Eng - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Cancer patient interest and perceptions of health behavior change programs.

Lawson Eng - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Feasibility pilot implementation of a low-dose CT screening program.

Joo Hyung Yoon - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Cancer patient attitudes and preferences towards smoking status assessment.

Lawson Eng - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Implementation of an electronic referral smoking cessation tool into clinical practice across cancer clinics of different disease sites and institutions.

Tamoor Afzaal - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Assessment of pulmonary function test abnormalities in adult survivors of childhood cancer.

Mylene Bassal - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Utilization of the sexual health service from the prostate cancer supportive care program: A chart review.

Jennifer Bossio - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Implementation of an electronic patient reported outcome system in a prostate cancer urology clinic.

Maria Spillane - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

The influence of an androgen deprivation therapy educational program on dyadic quality and intimacy for prostate cancer patients and their partners.

Erik Wibowo - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Androgen Tear

Mortality in people with psychotic disorders in Finland: A population-based 13-year follow-up study

J.Keinnen - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Drug user's self-efficacy to resist the urge of consuming these substances: Cross-cultural adaptation instrument

S.C.Vasconcelos - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of psychotherapy in improving the quality of life and social rehabilitation of patients with Psoriasis

V.Bialuhina - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Benefits of the functional ensemble of temperament framework in assessment of mental disorders: Examples

I.Trofimova - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Aluminum hydroxide / magnesium hydroxide / simethicone

Complex trauma, somatoform dissociations & energetics therapy

R.Kurz - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Methadone hydrochloride

Working with anxiety and depression from a Buddhism framework

A.Allen - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Expanding the diagnostic yield of germline genetic testing in cancer patients using deep learning.

Saud H Aldubayan - American Society of Clinical Oncology (ASCO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Interventions for reducing fear of childbirth: A systematic review and meta-analysis of clinical trials

V.MoghaddamHosseini - European Congress of Psychiatry (EPA) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved